Similar articles

• Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.

  Claudio T, Raftery MA. Claudio T, et al. J Supramol Struct. 1980;14(3):267-79. doi: 10.1002/jss.400140302. J Supramol Struct. 1980. PMID: 6971372
• Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.

  Mittag TW, Tormay A, Massa T. Mittag TW, et al. Mol Pharmacol. 1978 Jan;14(1):60-8. Mol Pharmacol. 1978. PMID: 625290 No abstract available.
• Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.

  Elias SB, Appel SH. Elias SB, et al. Ann Neurol. 1978 Sep;4(3):250-2. doi: 10.1002/ana.410040310. Ann Neurol. 1978. PMID: 718136
• Myasthenia gravis (first of two parts).

  Drachman DB. Drachman DB. N Engl J Med. 1978 Jan 19;298(3):136-42. doi: 10.1056/NEJM197801192980305. N Engl J Med. 1978. PMID: 201840 Review. No abstract available.
• Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.

  Drachman DB, Pestronk A, Stanley EF. Drachman DB, et al. Adv Cytopharmacol. 1979;3:237-44. Adv Cytopharmacol. 1979. PMID: 382787 Review. No abstract available.